Employing wearables to augment clinical trials offers enticing promise to healthcare and life science companies. We look at how employing wearables will require new processes and tools, as well as the new e-clinical partner models and technology partnerships that are likely to evolve.
- Map a Clear Business Benefit Outcome as Part of Your Technology Development Strategy for Using Wearables to Augment Clinical Trials
- Ensure Wearables Meet Requirements for Regulatory Compliance and Information Security, and Can Operate in Clinical Conditions
- U.S. Biotech Studying Ambulatory Observations in Patients With Parkinson's Disease Collects Fuzzy Data and Must Address Patient Education
- U.K. Pharmaceutical Company Sees Limitations in Wearable Device Design and Must Change Devices
- Small Research Firm Realizes a Third-Party Data Exchange Is Necessary After Inadvertently Capturing Too Much Patient Identifiable Data
- Pharma Company Attempts to Integrate the Device Directly Into Its Electronic Capture and Clinical System
Gartner Recommended Reading
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see
Guiding Principles on Independence and Objectivity.